Figure 3.
Kaplan–Meier curves of DFS and OS by molecular markers status among 330 patients with at least two invasive tumor foci. (A) The estimated 3-year DFS rates for the Homo and Hetero groups were 96.5% and 81.2%, respectively (p = 0.041). (B) The estimated 3-year OS rates for the Homo and Hetero groups were 99.5% and 95.8%, respectively (p = 0.059).